Let be real clear for you:
'The action of added insulin-like growth factor-I (IGF-I) and dihydrotestosterone (DHT) on steroid 5 alpha-reductase (5 alpha R) activity was studied using primary cultures of rat or human scrotal skin fibroblasts.'
'Since the effect of IGF-I was about 100 times that of androgen, we studied the possibility that androgen induction of the enzyme activity could be via IGF-I production.'
Conclusion:
These studies indicate that IGF-I may be an important regulator of skin 5 alpha R activity and, thus, may influence DHT formation.
^^^^
If they can draw such a conclusion, then why can't you? Skin is skin. 5ar/DHT causes hair growth all over the body.
-------------------------------------------------------------------------------------
docj077 said:
IGF-1 IS A PRO-GROWTH MOLECULE. LOWER LEVELS OF DHT ENCOURAGE AN INCREASE IN IGF-1 PRODUCTION CAUSING HAIR GROWTH AND REGROWTH
If you read up, no one disputed this. However, in this experiment DHT production was BLOCKED by finasteride. How about upregulating IGF-1 prudction without a 5ar inhibitor?
I think you'll find the outcome might be something like this:
Study 1:
'We evaluated the relations of plasma concentrations of IGF-1 and IGFBP-3 with vertex balding in middle-aged and elderly men.'
'Compared with men who were not balding, for a 1 standard deviation increase in plasma IGF-1 level (72.4 ng/mL), the OR for vertex balding was 1. 31 (95% CI, 0.95-1.81).'
CONCLUSION: Older men with vertex balding have lower circulating levels of IGFBP-3 and higher levels of IGF-1
Study 2:
'We assessed the relationship between circulating hormone measurements and both head and chest hair patterning in a sample of elderly men.'
'Fifty-one apparently healthy men older than 65 years of age were studied cross-sectionally. Head and chest hair patterning was assessed by a trained interviewer. Morning blood samples from all subjects were used for measurements of testosterone, estradiol, dehydroepiandrosterone sulfate, SHBG, and IGF-1.'
RESULTS: Results were obtained from logistic regression models, adjusting simultaneously for all the measured hormones and age. Men with higher levels of testosterone were more likely to have vertex baldness (odds ratio [OR] = 2.5, 95% confidence interval [CI: 0.9 to 7.8] per 194 ng/dL increment of testosterone). In addition, for each 59 ng/mL increase in IGF-1, the odds of having vertex baldness doubled (95% CI [1.0 to 4.6]). Those who were found to have higher circulating levels of SHBG were less likely to have dense hair on their chest (OR = 0.4, 95% CI [0.1 to 0.9] per 24 nmol/L increment in SHBG]).